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ABSTRACT 
 
The autophagosome, a double-membrane structure mediating degradation of 
cytoplasmic materials by macroautophagy, is formed in close proximity to the 
endoplasmic reticulum (ER). However, how the ER membrane is involved in 
autophagy initiation and to which membrane structures the autophagy-initiation 
complex is localized have not been fully characterized. Here, we were able to 
biochemically analyze autophagic intermediate membranes and show that the 
autophagy-initiation complex containing ULK and FIP200 first associates with the 
ER membrane. To further characterize the ER subdomain, we screened 
phospholipid biosynthetic enzymes and found that the autophagy-initiation 
complex localizes to phosphatidylinositol synthase (PIS)-enriched ER subdomains. 
Then, the initiation complex translocates to the ATG9A-positive autophagosome 
precursors in a PI3P-dependent manner. Depletion of phosphatidylinositol (PI) by 
targeting bacterial PI-specific phospholipase C to the PIS domain impairs 
recruitment of downstream autophagy factors and autophagosome formation. 
These findings suggest that the autophagy-initiation complex, the PIS-enriched ER 
subdomain, and ATG9A vesicles together initiate autophagosome formation. 
 
(152 words/Max 175 words) 
 
Key words: ATG9A/Autophagy/FIP200/Phosphatidylinositol synthase/The ULK 
complex   
 
  
 3
INTRODUCTION 
 
Macroautophagy (hereafter referred to as autophagy) is a catabolic process that is highly 
conserved among eukaryotes. When autophagy is induced, a part of the cytoplasm is 
surrounded by a membrane sac, termed the isolation membrane (also known as the 
phagophore). The isolation membrane expands to form a double-membrane 
autophagosome, which subsequently fuses with lysosomes for degradation of engulfed 
materials. Autophagosome formation involves a number of autophagy-related (ATG) 
proteins (Xie & Klionsky, 2007; Mizushima et al, 2011). Systematic hierarchical 
analysis revealed that the serine/threonine kinase Atg1 (UNC-51-like kinases (ULKs) in 
mammals) complex is the most upstream unit among the ATG proteins (Suzuki et al, 
2007; Itakura & Mizushima, 2010). This complex is composed of Atg1, Atg13, Atg17, 
Atg29, and Atg31 in yeast and ULK1 (or ULK2), ATG13, FIP200 (also known as 
RB1CC1 and partially homologous to yeast Atg11 and Atg17), and ATG101 in 
mammals (Mizushima et al, 2011). Atg17 and FIP200 are proposed to act as a scaffold 
for recruitment of downstream Atg proteins (Ragusa et al, 2012; Suzuki et al, 2013). 
Upon nutrient deprivation, Atg1/ULK is activated and phosphorylates downstream 
effectors, such as BECLIN1 (Russell et al, 2013), ATG14 (Park et al, 2016), and 
Atg9/ATG9A (Papinski et al, 2014; Zhou et al, 2017), to induce autophagosome 
formation. Thus, it is critical to understand the membrane structures/domains on which 
the activated Atg1/ULK complex acts. It is well known that early autophagic structures 
are formed in close apposition to the endoplasmic reticulum (ER)-related subdomains 
such as the omegasome (Axe et al, 2008), ER-mitochondrial contact site (Hamasaki et 
al, 2013), ER exit site (Graef et al, 2013; Suzuki et al, 2013), ER-Golgi intermediate 
compartment (ERGIC) (Ge et al, 2013), and isolation membrane-associated 
tubular/vesicular structures (Uemura et al, 2014). In mammalian cells, the ULK 
complex is translocated to punctate structures in tight association with the ER by both 
phosphatidylinositol (PI)3P-dependent and -independent mechanisms (Itakura & 
Mizushima, 2010; Karanasios et al, 2013). It was also reported that the ULK complex 
localizes to transferrin receptor-positive recycling endosomes (Longatti et al, 2012). 
However, the precise target membrane of the Atg1/ULK complex remains unknown.  
 Here, we performed systematic biochemical analysis using various ATG 
knockout cells and found that the ULK complex first localizes to PI synthase 
(PIS)-enriched ER subdomains and then translocates to the ATG9A-positive 
autophagosome precursors in a PI3P-dependent manner. PI in the PIS-enriched 
membrane is required for autophagosome formation. 
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RESULTS 
 
The autophagy-initiation complex associates with two distinct membrane 
structures 
 
To analyze the autophagic membranes, cell homogenates of mouse embryonic 
fibroblasts (MEFs) were subjected to flotation analysis. As for wild-type (WT) MEF 
homogenates, ATG proteins, except for the membrane protein ATG9A and 
membrane-bound microtubule-associated protein light chain 3 (LC3)-II, mostly 
remained in the bottom cytosolic fractions (Fig 1A). Consistent with a previous report 
(Chan et al, 2009), small proportions of the ULK complex components were found in 
floated membrane fractions under growing conditions. Flotation of FIP200, ATG13, 
ATG101, and WIPI2 into lighter-density fractions became clearer under starvation 
condition (Fig EV1A), indicating that autophagic membranes were floated. In order to 
enrich these autophagic membranes, we used several ATG-deficient cell lines, in which 
autophagosome formation is blocked at various steps leading to accumulation of 
autophagic intermediate structures at specific stages under growing conditions (Fig 
EV1B) (Itakura & Mizushima, 2010; Kageyama et al, 2011; Kishi-Itakura et al, 2014).  
 
We first analyzed homogenates obtained from ATG14 knockout (KO) and ATG3 KO 
MEFs. ATG14, a component of the PI 3-kinase complex, and ATG3 are required for the 
nucleation step and the elongation or closure step during autophagosome formation, 
respectively (Fig 1B) (Mizushima et al, 2011; Kishi-Itakura et al, 2014). Thus, early 
autophagosome precursors and elongating isolation membranes accumulate in ATG14 
KO and ATG3 KO cells, respectively. As for the ATG14 KO homogenate, in addition to 
ATG9A and LC3-II, the ULK complex components (FIP200, ATG13, ATG101, and 
ULK1) were floated into middle-density fractions (Fractions 5 to 7) even under growing 
conditions (Fig 1C, *). On the other hand, the isolation membrane-resident proteins 
WIPI2 and ATG5 were not clearly floated. These results suggest that these 
middle-density fractions contain autophagic precursor membranes, to which the ULK 
complex is recruited in a PI 3-kinase-independent manner. Similarly, when ATG3 KO 
homogenates were used, the ULK complex components and autophagy-specific PI 
3-kinase complex components (ATG14, VPS34, and BECLIN1) were floated into the 
middle-density fractions (Fractions 4 to 7) (Fig 1D, **). In contrast to ATG14 KO 
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homogenates, the ULK complex components, WIPI2, and ATG5 were also enriched in 
the top (lightest) fraction (Fraction 1) in ATG3 KO homogenates (Fig 1D, ***), 
suggesting that the top fraction contains elongating isolation membranes. To confirm 
whether the flotation of these ATG proteins was dependent on formation of the isolation 
membrane, the effect of acute inhibition of the PI 3-kinase, which is required for 
isolation membrane elongation (Kishi-Itakura et al, 2014), was examined using 
wortmannin. The amounts of the ULK complex components, WIPI2, and ATG5 in the 
top fraction were markedly reduced in ATG3 KO cells after wortmannin treatment (Fig 
1E and F), suggesting that isolation membranes are indeed enriched in the top fraction. 
On the other hand, the flotation of the ULK complex components into the 
middle-density fractions was unaffected by wortmannin treatment (Fig 1F), which is 
consistent with the results in ATG14 KO cells (Fig 1C). While the puncta of WIPI2, a 
PI3P-binding protein, were sensitive to wortmannin, a significant proportion of the 
FIP200 puncta was not (Fig EV1H). These results suggest that the ULK complex is 
sequentially recruited to the two distinct membrane structures with middle and light 
densities in PI3P-independent and -dependent manners, respectively. These structures 
can be separated using ATG14 KO and ATG3 KO cells. 
 
FIP200 tethers the ULK complex subunits to membranes 
 
Next, we examined which component of the ULK complex determines its membrane 
targeting. In FIP200 KO cells, ATG13, ATG101, and ULK1 were not clearly floated into 
the middle-density fractions (Fig EV1C). By contrast, FIP200 was floated in all of the 
ULK1/2 double KO (DKO), ATG13 KO, and ATG101 KO cells (Fig EV1D-F). 
ATG101 and ULK1 were not clearly floated in ATG13 KO cells (Fig EV1E). 
Consistently, FIP200 localized to punctate structures in ATG13 KO, ATG101 KO, and 
ULK1/2 DKO MEFs (Fig EV1G). These results suggest that FIP200 has the ability to 
target membranes independently of the other components of the ULK complex.  
 
FIP200 is co-purified with the ER-related membranes and ATG9A-positive 
isolation membranes 
 
Our flotation analysis demonstrated that a significant population of the ATG9A-positive 
membranes was also collected in the middle- and light-density fractions, in which the 
ULK complex components accumulated when autophagosome formation was blocked 
(Fig 1C and D, asterisks). In mammals, it has been reported that ATG9A dynamically 
 6
associates with the isolation membrane, but is not contained in the isolation membrane 
or autophagosomal membranes (Orsi et al, 2012; Lamb et al, 2016). On the other hand, 
in yeast, Atg9-containing vesicles are thought to be a seed membrane for 
autophagosome biogenesis and Atg9 is indeed incorporated into autophagic membranes 
(Yamamoto et al, 2012). These findings prompted us to investigate the relationship 
between the ULK complex and ATG9A vesicles in these fractions. When ATG9A 
vesicles were purified from the middle-density fractions derived from non-starved WT 
(Fig EV2A) and ATG14 KO MEF homogenates (Fig EV2B), RAB1A (a mammalian 
Ypt1 homolog) was co-precipitated (Fig 2A-C). This is consistent with previous reports 
that Ypt1 is recruited to Atg9 vesicles in yeast (Kakuta et al, 2012). However, FIP200 
was not detected in these FLAG-ATG9A immunoprecipitates from the middle-density 
fractions of WT or ATG14 KO MEFs (Fig 2B and C), although both ATG9A and 
FIP200 were present in these fractions in ATG14 KO MEFs (Fig EV2B). These data 
suggest that FIP200 is mainly recruited to membrane structures other than ATG9A 
vesicles in ATG14 KO MEFs. In line with this, FIP200 was clearly floated to the 
middle-density fractions in the absence of ATG9A (Fig EV2C). Furthermore, FIP200 
formed punctate structures in ATG9A KO MEFs (Fig EV1G), as did ULK1 (Itakura et 
al, 2012; Orsi et al, 2012). These results suggest that the ULK complex can target some 
membrane structures other than ATG9A vesicles at an early step during autophagosome 
formation. We further found that the middle-density fractions contained the ER 
membranes and, in these fractions of ATG14 KO homogenates, FIP200 was 
co-precipitated with ER membranes purified with FLAG-tagged SEC61B (Fig 2D). 
These results suggest that the ULK complex localizes to the ER-related membrane in 
the absence of autophagy-specific PI 3-kinase.  
 
Although FIP200 and ATG9A were not co-purified in the middle-density fractions of 
ATG14 KO homogenate, FIP200 and WIPI2, another isolation membrane protein, were 
co-purified with FLAG-ATG9A from the top fraction of ATG3 KO homogenates (Fig 
3A). These results suggest that FIP200 resides on isolation membranes together with 
ATG9A in ATG3 KO MEFs. In contrast to ATG14 KO homogenates (Fig 2C), small 
amounts of FIP200 and WIPI2 were co-precipitated with FLAG-ATG9A from the 
middle-density fractions of ATG3 KO homogenates (Fig 3B). Similarly, SEC61B and 
GFP-ATG14 were co-precipitated with FLAG-ATG9A in these middle fractions (Fig 3B 
and C). SEC61B was co-precipitated with FLAG-ATG9A from the middle-density 
fractions of ATG3 KO homogenates more efficiently than from those of WT or ATG14 
KO homogenates (Fig 2B and C). These data suggest that ATG9A-containing 
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autophagosome precursor membranes are associated with the ER in ATG3 KO cells. 
Overall, we conclude that FIP200 can be recruited to two different membranes: the 
ER-related membrane (ATG14 KO, Fractions 4-7) and the isolation membrane (ATG3 
KO, Fraction 1) (Fig 3D). The co-purification of ATG9A, FIP200, WIPI2, ATG14, and 
SEC61B from the middle-density fractions of ATG3 KO homogenates would reflect the 
ER-isolation membrane contact (ATG3 KO, Fractions 4-7) (Fig 3D).  
 
FIP200 is recruited to the PIS-enriched ER subdomain at the initiation stage 
 
In spite of the fact that FIP200 associates with the ER membrane at an early stage of 
autophagy, it does not show an ER-like reticular pattern but a punctate distribution. This 
led us to hypothesize that FIP200 might be recruited to an ER subdomain. The ER is 
known to be the major site of cellular phospholipid synthesis, which would be required 
for autophagosome biogenesis. Recent studies have demonstrated that several 
phospholipid-metabolizing enzymes are segregated on the ER membrane (English & 
Voeltz, 2013; Pol et al, 2014). To characterize the ER subdomain that associates with 
FIP200, we screened phospholipid biosynthetic enzymes involved in the de novo 
synthesis and remodeling pathways that colocalized with FIP200 (Fig 4A) (Shindou & 
Shimizu, 2009; Pol et al, 2014). To facilitate the accumulation of FIP200 at the ER 
subdomain, cells were treated with wortmannin. We found that phosphatidylinositol 
synthase (PIS), cholinephosphotransferase 1 (CPT1), 
choline/ethanolaminephosphotransferase 1 (CEPT1), phosphatidylserine synthase 1 
(PSS1), and phospholipase D1A (PLD1A) were colocalized with FIP200 in these 
wortmannin-treated cells under starvation conditions (Fig 4B). Among these enzymes 
identified, we focused on PIS because this enzyme catalyzes the formation of PI, which 
is a precursor of PI3P required for autophagosome formation (Kihara et al, 2001). It was 
reported that PIS localizes to unique compartments: PIS is located in a highly dynamic 
ER-related compartment (Kim et al, 2011) and leading edges of ER tubules (English & 
Voeltz, 2013). When autophagosome formation was blocked at an early stage by 
wortmannin treatment, more than 70% of the FIP200 puncta were colocalized with 
PIS-GFP (Fig 5A and B), suggesting that FIP200 is recruited to PIS puncta at an early 
stage. PIS-GFP was not degraded in response to starvation unlike p62, a typical 
autophagy substrate (Fig EV3), ruling out the possibility that PIS accumulates as an 
autophagic substrate. In these wortmannin-treated starved cells, PIS and FIP200 
double-positive puncta did not colocalize with the ER exit site marker SEC31A or 
mitochondria (Fig 5C and D). Furthermore, clearly separated PIS structures did not 
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colocalize with ERGIC53 under wortmannin-treated conditions (Fig EV4). These 
results suggest that the PIS puncta are distinct from the ERGIC, ER exit site, and 
ER-mitochondrial contact site. The colocalization of PIS and FIP200 was also observed 
in ATG14 KO MEFs, in which early autophagic structures accumulated (Fig 5A). Also, 
we observed biochemically that FIP200 associated with PIS-enriched membranes 
purified from ATG14 KO MEFs (Fig 5E). This association disappeared in the presence 
of detergent, suggesting that the FIP200 co-precipitation was not simply caused by 
non-physiological aggregation but in a membrane-dependent manner. Moreover, in line 
with our model (Fig 3D; ATG14 KO, Fractions 4-7), co-precipitation of ATG9A with 
PIS-enriched membranes was not observed (Fig 5E). Overall, we conclude that FIP200 
is recruited to the PIS-enriched ER subdomain at an early stage of autophagy, upstream 
of the action of PI 3-kinase. 
 
The ULK complex forms a punctate structure on PIS-positive membranes 
 
To further characterize the localization of FIP200, we used a super-resolution structured 
illumination microscope (SR-SIM), which has ~120-nm lateral resolution. In starved 
cells, approximately 20% of FIP200 puncta colocalized with PIS-GFP almost 
completely (Fig 6A right top panels, and C), whereas more than 50% of FIP200 puncta 
only partially associated with PIS-GFP-positive structures (Fig 6A right bottom panels, 
and C). These results indicate that FIP200 at least partially colocalizes with PIS-GFP 
even under wortmannin-untreated condition. By contrast, most FIP200 puncta 
colocalized with PIS-GFP puncta in wortmannin-treated starved cells (Fig 6B and C), 
which is consistent with that observed by conventional confocal microscopy (Fig 5A 
and B). 
 
Next, we investigated puncta formation of the ULK complex in live cells. Live imaging 
analysis of super enhanced cyan fluorescent protein (SECFP)-PIS showed that 
Venus-ULK1 puncta were formed on SECFP-PIS puncta (Figs 7A and B and Movie 
EV1 and 2). Before disappearance of the ULK1 signal, a part of the ULK1 structures 
seemed to dissociate from the PIS puncta (yellow arrows in Fig 7A and B), which 
suggests a translocation of the ULK complex to distinct autophagosome precursors. 
Quantitative analysis revealed that more than 50% of Venus-ULK1 puncta emerged on 
the PIS puncta (Fig 7C). The remaining ULK1 puncta were formed on PIS-positive 
reticular structures, which may represent similar ER subdomains but the amount of PIS 
was not large enough to be detected as puncta (Figs 7C and Movie EV3). Considering 
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that the colocalization ratio between the ULK complex components and PIS puncta was 
relatively higher in wortmannin-treated cells (Figs 5A and B and 6) and in ATG14 KO 
cells (Fig 5A), autophagy inhibition at early stages likely causes accumulation of PIS 
(and other enzymes such as CPT1 and CEPT1) at the autophagosome formation site. 
Collectively, these results suggest that the ULK complex forms a punctate structure on 
PIS-enriched ER subdomain at an early stage of autophagy. 
 
PI is required for isolation membrane formation 
 
We finally sought to examine whether PI in the PIS-enriched membrane is required for 
autophagy. Since RNAi-mediated knockdown of PIS did not induce significant 
reduction in the cellular PI level (unpublished observations), Listeria monocytogenes 
PI-specific phospholipase C (PIPLC), which degrades unphosphorylated PI, was used to 
deplete PI (Kim et al, 2011). To validate the effect of PIPLC, cell homogenates were 
incubated with recombinant PIPLC and subjected to lipid analysis. The level of PI was 
significantly reduced in the presence of recombinant PIPLC, whereas the levels of other 
phospholipids were not affected (Fig EV5A), indicating that PIPLC can specifically 
degrade PI in vitro. To target PIPLC to the PIS-enriched membrane in vivo, we 
engineered cells that express PIPLC fused to a catalytic inactive mutant of PIS H105Q 
(PISHQ) under the control of doxycycline (PISHQ-GFP-PIPLC MEFs). Forced 
expression of PISHQ-GFP-PIPLC was effective and reduced the level of PI (Fig 8A). In 
contrast, the levels of other phospholipids were relatively maintained or increased as a 
compensatory reaction (Fig EV5B). In these cells expressing PISHQ-GFP-PIPLC, 
although the cellular PI level was reduced to only ~50% of that in DOX-untreated cells, 
autophagic activity was profoundly suppressed; starvation-induced LC3 turnover and 
p62 degradation were inhibited (Fig 8B). Furthermore, FIP200-positive but 
PI3P-binding WIPI2-negative abnormal autophagic structures accumulated (Fig 8C and 
D). By contrast, the number of WIPI2-positive puncta was significantly reduced by the 
expression of PISHQ-GFP-PIPLC (Fig 8D-F), suggesting that PI production at the PIS 
domain is important for autophagosome formation. In these cells, punctate structures 
labeled with RFP-2xFYVE, a PI3P probe that primarily labels endosomes were also 
abolished, suggesting a reduction in not only autophagosomal but also the total cellular 
PI3P level (Fig 8F). On the other hand, cytosolic PIPLC did not affect the formation of 
WIPI2 puncta (Fig 8G). These data suggest that PI produced at the PIS-enriched 
subdomain actively contributes to autophagy initiation through a direct effect on 
autophagic structures and/or indirect effects on other membrane compartments.  
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DISCUSSION 
 
In this study, we biochemically analyze the membranes carrying upstream ATG proteins 
and found that FIP200 can be recruited to two different membranes: the ER-related 
membrane and the isolation membrane carrying ATG9A. We also identified the 
PIS-enriched ER subdomain as a site for the initiation of autophagosome formation. 
Furthermore, we showed that PI reduction in the PIS-enriched membrane significantly 
inhibited autophagosome formation. Based on these results, we hypothesize that the 
autophagy-initiating ULK complex first translocates to the PIS-enriched ER subdomain 
in an ATG9A- and PI 3-kinase-independent manner (Fig 8H). Next, ATG9A-containing 
vesicles, which could be a seed for autophagosome biogenesis, associate with this 
domain, and the ULK complex translocates to ATG9A vesicles to elongate the 
membrane.  
 
The ULK complex targets to two distinct membranes: the ER-related membrane 
and ATG9A-enriched membrane 
We have shown that ATG proteins are floated into membrane fractions derived from 
ATG KO cells (Fig 1). To our knowledge, this is the first systematic biochemical 
analysis of membrane association status of endogenous ATG proteins. We have also 
demonstrated the physical interaction of ULK complex component with the ER 
membrane and ATG9A-positive isolation membrane (Figs 2 and 3). As well as in yeast 
(Yamamoto et al, 2012), our results suggest that the ATG9A vesicle can be a seed 
membrane of the autophagosome in mammals. However, our results do not necessarily 
rule out the possibility that mammalian ATG9A fulfills other functions by its transient 
interaction with autophagic membranes (Orsi et al, 2012; Lamb et al, 2016), rather than 
acting only as a seed membrane of the autophagosome. Currently, it is not clear why the 
ULK complex needs to be recruited to the ER membrane in addition to ATG9A-positive 
membranes. One possibility is that the ULK complex might induce reorganization of the 
ER membrane and stimulate the formation of membrane contacts between the ER and 
ATG9A vesicles. In line with this model, it was recently reported that Atg1 kinase 
complex can tether Atg9-vesicles in vitro experiments (Rao et al, 2016). A similar 
mechanism might mediate tethering between the ER and ATG9A vesicles. 
 The recruitment mechanism of the ULK complex seems to be complicated. 
Consistent with a previous report that Atg17, a yeast counterpart of FIP200, can be 
recruited to pre-autophagosomal structure in atg1Δ and atg13Δ cells (Suzuki et al, 2007), 
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FIP200 has an ability to associate with membranes independently of the other ULK 
complex components (Fig EV1). It is also possible that FIP200 is recruited to the 
membrane via its interaction with the ATG12—ATG5–ATG16L1 complex (Fujita et al, 
2013; Gammoh et al, 2013; Nishimura et al, 2013), which further interacts with WIPI2 
(Dooley et al, 2014). A part of WIPI2 can associate with membranes even in the 
presence of wortmannin (Polson et al, 2010). By contrast, previous studies showed that 
other Atg1/ULK complex components have lipid-binding domains. For example, the N 
terminus of ATG13 interacts with acidic phospholipids (Karanasios et al, 2013). The 
EAT domain of yeast Atg1 can be co-precipitated with small unilamellar vesicles 
(Ragusa et al, 2012) and Atg1 also shows high affinity with PI-containing liposomes in 
vitro (Rao et al, 2016). During autophagosome formation, the ULK complex seems to 
translocate from the ER to ATG9A vesicles, potential autophagosome precursors (Fig 
7A and B), although we do not rule out a possibility that additional cytosolic ULK 
complexes are also directly recruited. This change may be caused by production of PI3P 
because PI 3-kinase activity is known to stabilize the ULK1 complex on the autophagic 
membranes (Karanasios et al, 2013). Furthermore, the ULK complex components 
interact with ATG8 family proteins and are recruited to autophagic membranes 
dependently on their LC3-interacting region motifs (Alemu et al, 2012). All these 
factors could determine the unique behavior of the Atg1/ULK complex. 
 We previously reported that ULK1, ATG13, FIP200, and ATG101 form a stable 
complex in the cytosol (Hosokawa et al, 2009a; Hosokawa et al, 2009b). By contrast, in 
the present study, behaviors of ATG13 and FIP200 are somewhat different from that of 
ULK1. One possibility is that FIP200 and ATG13 could associate with the membrane 
more tightly than ULK1 and, therefore, ULK1 is released from the membranes during 
sample preparation and flotation experiments. Another possibility is that the 
stoichiometry of the complex subunits is different between the cytosolic and membrane 
complexes.  
 
Contribution of PIS-enriched ER subdomains in the initiation stage of autophagy 
We have uncovered that early autophagic structures are formed in close apposition to 
the PIS-enriched ER subdomains. In wortmannin-treated condition (Fig 4) and 
ATG14KO cells (unpublished observations), other phospholipid biosynthetic enzymes, 
such as PSS1, CPT1, CEPT1 and PLD1A, were also co-localized with the ULK 
complex. Inhibition of autophagosome formation at an early stage might affect local 
phospholipid metabolism and induce recruitment of phospholipid biosynthetic enzymes 
to the autophagosome formation site via an unknown feedback loop. While only PIS 
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clearly shows punctate structures that co-localize with the ULK complex in 
wortmannin-untreated cells, we speculate that other enzymes are also present at the 
same membrane at undetectable levels to facilitate autophagosome formation. The 
involvement of other phospholipid biosynthetic enzymes in autophagy have been 
investigated. CPT1 positively regulates autophagosome formation under oleic 
acid-treated conditions (Dupont et al, 2014). The role for PLD1 is rather controversial; 
it could regulate autophagy either positively or negatively (Dall'Armi et al, 2010; Bae et 
al, 2014; Jang et al, 2014; Holland et al, 2016). How these enzymes contribute to 
autophagy initiation, autophagosome formation, or autophagosome maturation remains 
to be determined in more detail. 
 The presence of phospholipid biosynthetic enzymes at the site of 
autophagosome formation suggests that newly synthesized PI and other phospholipids 
are directly used for autophagosome formation. Consistent with this idea, we showed 
that PI in the PIS-enriched membrane is required for autophagosome formation (Fig 
8B-E). However, as the total cellular PI3P level was also reduced by expression of 
PISHQ-GFP-PIPLC (Fig 8F), we cannot rule out a possibility that PI depletion affects 
autophagosome formation through an indirect effect on other membranes. Membrane 
contacts between the ER membrane and the isolation membrane have been observed by 
EM analysis in several previous studies (Kovacs et al, 2007; Hayashi-Nishino et al, 
2009; Yla-Anttila et al, 2009; Uemura et al, 2014). There is accumulating evidence that 
phospholipids are synthesized and transported at membrane contact sites between ER 
and other organelles (Drin, 2014; Prinz, 2014; Raiborg et al, 2015; Levine & Patel, 
2016; Phillips & Voeltz, 2016). Therefore, contact sites between the ER and 
ATG9A-enriched membranes might facilitate transport of newly synthesized PI and 
other phospholipids between these two compartments. However, factors involved in 
non-vesicular lipid transport between the ER and ATG9A-enriched membranes remain 
unidentified. Future studies are needed to elucidate if lipid transfer proteins contribute 
to autophagosome formation. 
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MATERIALS AND METHODS 
 
Plasmids, antibodies, and reagents 
cDNAs encoding the full-length of PIS (NP_080914, Open biosystems, Huntsville, AL), 
CPT1 (NP_064629, Open biosystems), EPT1 (NP_277040, Kazusa DNA Research 
Institute, Chiba, Japan), CEPT1 (NP_001007795, Open biosystems), ECT 
(NP_001171846), CCTβ2 (NP_004836), PSS1 (NP_055569), PSS2 (NP_110410), PSD 
(NP_055153), PEMT (NP_680477), CDS1 (NP_001254), CDS2 (NP_003809), PLD1A 
(NP_002653, Kazusa DNA Research Institute), PLD2 (NP_002654, Kazusa DNA 
Research Institute), DGAT1 (NP_036211), DGAT2 (NP_115953), LIPIN1A 
(NP_663731), LIPIN1B (NP_056578, Open biosystems), LIPIN2 (NP_055461), 
LPAAT1/AGPAT1 (NP_116130), LPAAT2/AGPAT2 (NP_006403), 
LPAAT3/AGPAT3 (NP_064517), AGPAT5 (NP_060831), GPAT1 (NP_065969), 
GPAT3 (NP_116106), GPAT4 (NP_848934), LPCAT1 (NP_079106), LPCAT2 
(NP_060309), LPCAT3/MBOAT5 (NP_005759), LPEAT1/MBOAT1 (NP_001073949), 
LPEAT2/LPCAT4 (NP_705841), PGS (NP_077733), LPIAT1/MBOAT7 (NP_077274), 
LCLAT1/LYCAT (NP_872357), LPGAT1 (NP_055688), PTPMT1 (NP_783859, 
Kazusa DNA Research Institute), SEC61B (NP_006799), and ATG14 (NP_055739) 
were amplified by PCR and subcloned into pMRX-IP backbone vectors together with 
the EGFP or FLAG tag. PIS cDNA was cloned into pMRX-IP with SECFP (provided 
by Atsushi Miyawaki, Riken) to generate pMRX-IP-SECFP-PIS. mRFP-2xFYVE was 
subcloned into pMRX-IP vector. ATG9A (NP_076990) was subcloned into 
N-TAP-MXs-puro vector (Yamaguchi et al, 2013). Listeria monocytogenes PIPLC 
cDNA (Kim et al, 2011) was subcloned into pGEX-6P-3 vector (GE Healthcare, 
Piscataway, NJ). pMRX-IP-PIS(H105Q)-GFP was generated by inverse PCR. For 
generation of pCW57.1-PISHQ-GFP-PIPLC and pCW57.1-RFP-PIPLC plasmid, 
PIS(H105Q)-GFP, PIPLC, and RFP-PIPLC were subcloned into pCW57.1 backbone 
vector. pMRX-IP-Venus-ULK1 plasmid has been previously described 
(Koyama-Honda et al, 2013). Antibodies used for immunoblotting: rabbit polyclonal 
anti-FIP200 (17250-1-AP, Protein Tech, Chicago, IL), anti-ATG13 (SAB4200100, 
Sigma-Aldrich, St. Louis, MO), anti-ATG101 (Hosokawa et al, 2009b), anti-ULK1 
(A7481, Sigma-Aldrich), anti-ATG9A (Itakura et al, 2012), anti-ATG14 (Itakura et al, 
2008), anti-WIPI2 (SAB4200400, Sigma-Aldrich), anti-ATG5 (A0731, Sigma-Aldrich), 
anti-LC3 (#1) (Hosokawa et al, 2006), anti-ERGIC53 (E1031, Sigma-Aldrich), 
anti-SEC61B (07-205, Millipore, Billerica, MA), anti-FLAG (F7425, Sigma-Aldrich), 
anti-RAB1A (C-19, Santa Cruz, Dallas, TX), anti-GFP (A6455, Invitrogen, Carlsbad, 
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CA), anti-ATG3 (A3231, Sigma-Aldrich), anti-p62 (PM045, MBL, Nagoya, Japan), 
anti-VPS34 (#3811, Cell Signaling, Beverly, USA), and anti-BECLIN1 (#3738, Cell 
Signaling) antibodies, mouse monoclonal anti-HSP90 (clone 68, BD Biosciences, San 
Jose, CA), anti-β ACTIN (clone AC74, Sigma-Aldrich), anti-LC3 (clone 1703, Cosmo 
bio, Tokyo, Japan), anti-FLAG (clone M2, Sigma-Aldrich) and anti-DYKDDDK (clone 
1E6, Wako, Osaka, Japan) antibodies were used. Antibodies used for immunostaining: 
rabbit polyclonal anti-FIP200 (see above) and anti-ERGIC53 (see above) antibodies, 
mouse monoclonal anti-SEC31A (clone 32, BD Biosciences) and anti-WIPI2 (clone 
2A2, Millipore) antibodies, AlexaFluor 488-conjugated anti-rabbit IgG, AlexaFluor 
568-conjugated anti-mouse IgG and anti-rabbit IgG, and AlexaFluor 660-conjugated 
anti-mouse IgG and anti-rabbit IgG secondary antibodies (Molecular Probes, Eugene, 
OR) were used. Doxycycline hydrochloride (Dox) and wortmannin were purchased 
from Sigma-Aldrich. Bafilomycin A1 was purchased from Wako.  
 
Cell culture and transfection 
ATG14 KO (Nishimura et al, 2013), ATG3 KO (Sou et al, 2008), FIP200 KO (Gan et al, 
2006), ATG13 KO (Kaizuka & Mizushima, 2015), ATG101 KO (Suzuki et al, 2015), 
ULK1/2 DKO (Cheong et al, 2011), and ATG9A KO MEFs (Saitoh et al, 2009) were 
generated previously. Stable cell lines were generated as follows: HEK293T cells were 
transiently transfected using Lipofectamine 2000 (Invitrogen) reagent with the indicated 
retrovirus vector (pCG-VSV-G and pCG-gag-pol for retrovirus infection) or lentivirus 
vector (pCW57-PISHQ-GFP-PIPLC, pCMV-VSVG, and psPAX2 for lentivirus 
infection). WT and ATG3 KO MEFs were also transfected using the indicated 
retrovirus or lentivirus. Cells were cultured in DMEM supplemented with 10% fetal 
bovine serum (FBS) in a 5% CO2 incubator. For starvation treatment, cells were washed 
twice with phosphate-buffered saline (PBS) and incubated in amino acid-free DMEM 
without FBS (starvation medium).  
 
Optiprep flotation analysis  
Cells from four to eight 10-cm dishes were harvested and washed twice with ice-cold 
PBS. The cell pellets were collected after centrifugation at 600 × g for 5 min and 
resuspended in 2 ml ice-cold homogenization buffer (250 mM sucrose, 20 mM 
Hepes-KOH (pH7.4), 1 mM EDTA, 1 mM phenylmethanesulfonyl fluoride, complete 
EDTA-free protease inhibitor (Roche, Indianapolis, IN)). Cells were then disrupted by 
N2 cavitation (Parr Instrument, Moline, IL) (800 psi, 10 min, 4°C). The homogenized 
cells were centrifuged twice at 3,000 × g for 10 min to remove cell debris and 
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undisrupted cells. The supernatant was diluted with an equal volume of OptiPrep 
(Sigma, St. Louis, MO). Discontinuous OptiPrep gradients were generated in SW41 
tubes (Beckman Instruments, Berkeley, CA) by overlaying the following OptiPrep 
solutions all in homogenization buffer: 2.4 ml of the diluted supernatant in 30% 
OptiPrep, 2.4 ml in 25%, 2.4 ml in 20%, 2 ml in 15%, 2 ml in 10%, 0.5 ml in 5%, and 
0.5 ml in 0%. The gradients were centrifuged at 150,200 × g in SW41Ti rotors 
(Beckman Instruments) for 3 h and subsequently 14 fractions (0.85 ml each) were 
collected from the top. Fractions were diluted with an equal volume of homogenization 
buffer and membranes were enriched by centrifugation at 100,000 × g for 40 min. The 
pellets were solubilized with SDS-PAGE sample buffer and heated at 55°C for 10 min. 
 
Immunoisolation of membrane fractions 
Anti-FLAG magnetic beads were prepared according to the manufacturer’s instructions. 
In brief, 1 mg NHS-FG magnetic beads (TAS8848N1141, Tamagawa Seiki, Nagano, 
Japan) was pre-treated with methanol and incubated with 100 µl anti-FLAG M2 or 
anti-DYKDDDDK antibodies (0.25 µg/µl, dissolved in 25 mM MES-NaOH, pH6.0) at 
4°C for 30 min. The magnetic beads were treated with 1 M ethanolamine to block 
unreacted NHS-ester groups at 4°C for 16 h, washed three times in washing buffer (10 
mM Hepes-KOH (pH7.9), 50 mM KCl, 1 mM EDTA, 10% glycerol), and stored in 200 
µl washing buffer at 4°C until use. Anti-FLAG magnetic beads and 1.5 ml tubes 
(MS-4215M, Sumitomo Bakelite, Akita, Japan) were blocked with homogenization 
buffer containing 250 mM NaCl and 1% BSA for 1 h at 4°C. MEFs stably expressing 
the indicated FLAG-tagged protein were subjected to Optiprep flotation analysis as 
described above. 400 µl of the indicated fractions were mixed with 20 µl 5 M NaCl and 
20 µl anti-FLAG magnetic beads (50% slurry), and rotated for 2 h at 4°C. The magnetic 
beads were washed four times with homogenization buffer containing 250 mM NaCl 
and 1% BSA. The magnetic beads were transferred to a new 1.5 ml tube and washed 
with homogenization buffer containing 250 mM NaCl. The immunoprecipitated 
membranes were solubilized with 60 µl of 1 × SDS-PAGE sample buffer and heated at 
55°C for 10 min. 
 
Immunoblotting 
Cells were collected in ice-cold PBS by scraping and precipitated by centrifugation at 
1,000 × g for 3 min. Precipitated cells were suspended in 0.1 ml homogenization buffer 
and homogenized by sonication (3 × 5 s; Astrason, XL2020 (Misonix, Inc., Farmingdale, 
NY)). After centrifugation at 1,000 × g for 20 min, the protein concentration of the 
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supernatant was determined using the BCA method (Pierce Chemical Co., Rockford, 
IL), mixed with SDS-PAGE sample buffer, and heated at 55°C for 10 min. Samples 
were subsequently separated by SDS-PAGE and transferred to Immobilon-P 
polyvinylidene difluoride membranes (Millipore). Immunoblot analysis was performed 
with the indicated antibodies and visualized with Super-Signal West Pico 
Chemiluminescent substrate (Pierce Chemical Co.) or Immobilon Western 
Chemiluminescent HRP substrate (Millipore). Signal intensities were analyzed using 
the LAS-4000mini image analyzer (GE Healthcare).  
 
Lipid analysis 
Recombinant PIPLC was prepared as follows. pGEX6P-3-PIPLC were transformed into 
E.coli strain BL21. GST-PIPLC expression was induced with 0.5 mM IPTG at 18°C. 
GST-PIPLC recombinant protein was purified with glutathione-Sepharose (GE 
Healthcare) and cleaved from GST using PreScission protease (50 mM Tris-HCl (pH 
7.4), 400 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, and 0.1 U/µl PreScission 
protease). Untagged PIPLC protein was dialyzed with PBS for 3 days and stored at 
-80°C. Phospholipids were extracted using the methanol method (Zhao & Xu, 2010). In 
brief, methanol was added into cell pellets, sonicated in a bath sonicator for 2 min, and 
centrifuged at 15,000 × g for 10 min. The supernatant was applied to Cosmospin Filter 
G (Nacalai Tesque, Kyoto, Japan) and centrifuged at 5,000 × g for 5 min. 10 µl of 
sample was injected into the LC-ESI-MS/MS system. LC-ESI-MS/MS analysis was 
performed using a Shimadzu Nexera ultra high performance liquid chromatography 
system (Shimadzu, Kyoto, Japan) coupled with a QTRAP 4500 hybrid triple quadrupole 
linear ion trap mass spectrometer (AB SCIEX, Toronto, Canada). Chromatographic 
separation was performed on an Acquity UPLC HSS T3 column (100 mm × 2.1 mm, 
1.8 µm; Waters) maintained at 40°C using mobile phase A (water/methanol (50/50, v/v) 
containing 10 mM ammonium acetate and 0.2% acetic acid) and mobile phase B 
(isopropanol/acetone (50/50, v/v)) in a gradient program (0–3 min: 30% B→50% B; 3–
24 min: 50% B→90% B; 24–28 min: 30% B) with a flow rate of 0.3 ml/min. Neutral 
loss scans of 74 and 87 Da in the negative ion mode were used to detect 
phosphatidylcholine and phosphatidylserine, respectively. Precursor ion scan of m/z 196, 
241, 153, and 384 in the negative ion mode was used to detect 
phosphatidylethanolamine, phosphatidylinositol, phosphatidic acid, and cytidine 
diphosphate-diacylglycerol, respectively. The total cycle time was 1.7 s, which allowed 
the collection of sufficient data points over the chromatographic peak. The instrument 
parameters were as follows: curtain gas, 10 psi; collision gas, 7 arb. unit; ionspray 
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voltage, -4500 V; temperature, 700°C; ion source gas 1, 30 psi; ion source gas 2, 70 psi; 
declustering potential, -96 V; entrance potential, -10 V; collision energy, -36 V; 
collision cell exit potential, -15.4 V.  
 
Fluorescence microscopy 
Cells grown on coverslips were fixed with 4% paraformaldehyde, permeabilized using 
50 μg/ml digitonin, and then stained with specific antibodies. For mitochondrial staining, 
cells were pretreated with 50 nM Mitotracker Red CMXRos (Molecular Probes) for 15 
min before fixation. For ERGIC53 staining, cells were fixed with methanol. These cells 
were observed using a confocal laser microscope FV1000D IX81 (Olympus, Tokyo, 
Japan) with FV12-HSD system using a 60x PlanApoN oil immersion lens (1.42 NA; 
Olympus). Images were acquired at room temperature using FV10-ASW software 
(Olympus). For the final output, images were processed using Adobe Photoshop 7.0.1 
software. The number of dots was determined using MetaMorph software (Molecular 
Devices, Sunnyvale, CA) as follows: dots were extracted using the top hat operation, 
and a binary image was created. Small dots were removed using an open operation. The 
number of dots was counted using the integrated morphometry analysis program. False 
dots were removed by comparison with the original image. 
 
Super-resolution structured illumination microscopy (SR-SIM) 
Super-resolution imaging was performed on a Zeiss Elyra PS.1 microscope equipped 
with a Plan-Apochromat 63× /1.4 oil DIC M27 objective and a sCMOS camera (1280 x 
1280 pixels of 6.5 x 6.5 µm). Fifteen images per plane (5 phases and 3 angles) were 
acquired with the 561 nm (34 µm grating period) and the 488 nm (28 µm gating period) 
lasers. For channel alignment, 0.2-µm multicolored beads immobilized on a sample 
coverslip were imaged using the same image acquisition settings and used to correct for 
chromatic shifts between different color channels. Raw data was processed using Zeiss 
Zen software. 
 
Live-cell imaging 
For autophagy induction, cells were washed twice with PBS and incubated in starvation 
medium. Images were acquired with a 60× PlanAPO oil-immersion objective lens (1.42 
NA; Olympus), using a Deltavision microscope system (GE Healthcare) coupled with 
an Olympus IX81-ZDC and a cooled CCD camera CoolSNAP HQ2 (Photometrics, 
Tucson, AZ). WT MEFs stably expressing SECFP-PIS and Venus-ULK1 were grown 
on a glass bottom dish (11-004-006) (IWAKI, Tokyo, Japan). During live-cell imaging, 
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the culture dish was mounted in a chamber INUB-ONI-F2 (TOKAI HIT, Shizuoka, 
Japan) to maintain the culture conditions (37°C and 5% CO2). SECFP-PIS and 
Venus-ULK1 were illuminated with a mercury arc lamp attenuated to 5% and 50% by 
neutral density filters, respectively. Exposure times were 0.2 s for SECFP-PIS and 0.5 s 
for Venus-ULK1. Time-lapse images were acquired at 10-s intervals. Deconvoluted 
images were obtained using softWoRx software. To find newly formed ULK1, 
sequential images were subjected to single-particle tracking analysis using MetaMorph 
software. For the final output, images were processed using Image J and Adobe 
Photoshop 7.0.1 software.  
 
Data analysis 
Differences were statistically analyzed by two-tailed Mann-Whitney U-test. Statistical 
analysis was carried out using GraphPad Prism 6 (GraphPad Software, La Jolla, CA). 
All data are presented as the mean ± SEM. Reproducibility of all results reported here 
was confirmed. 
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Figure legends 
 
Figure 1. Flotation of ATG proteins derived from ATG14 KO and ATG3 KO cell 
homogenates. 
(A) Optiprep membrane flotation analysis of WT MEFs cultured in regular DMEM 
(Growing). After fractionation, each fraction was centrifuged at 100,000 × g for 40 min 
to enrich the membranes.  
(B) Autophagosome formation. ATG14 and ATG3 are required for the nucleation and 
elongation or closure steps during autophagosome formation, respectively. 
(C, D) ATG14 KO (C) and ATG3 KO MEFs (D) were cultured in regular DMEM and 
subjected to Optiprep flotation analysis as described above. Asterisks indicate the 
flotation of ATG proteins of ATG14 KO and ATG3 KO homogenates. Arrow indicates 
the position of ATG14 (A, D). 
(E, F) ATG3 KO MEFs stably expressing FLAG-ATG9A were cultured in regular 
DMEM (E) or starvation medium in the presence of 200 nM wortmannin (Starv. + WM) 
(F) for 2 h. Note that wortmannin treatment significantly reduced the amounts of the 
ULK complex components, WIPI2, and ATG5 in the top fraction (compare † in E with 
†† in F).  
 
Figure 2. FIP200 is co-purified with the ER membranes from ATG14 KO MEF 
homogenates. 
(A) Experimental scheme of autophagic membrane purification. Cells stably expressing 
FLAG-ATG9A were cultured in regular DMEM and subjected to Optiprep flotation 
analysis. FLAG-ATG9A-enriched membranes were precipitated from the middle 
density fractions (Fr. 4-7 mixture) or the top fraction (Fr. 1) under detergent-free 
conditions using anti-FLAG antibody-coated magnetic beads. 
(B, C) Purification of ATG9A-positive membranes. WT (B) and ATG14 KO MEFs (C) 
expressing FLAG-ATG9A were cultured in regular DMEM and subjected to Optiprep 
flotation analysis as described in the legend to Fig 1. FLAG-ATG9A-enriched 
membranes were purified from middle-density fractions derived from WT (B) (Fig 
EV2A) and ATG14 KO MEF homogenates (C) (Fig EV2B). The resulting precipitates 
were examined by immunoblot analysis with the indicated antibodies. 
(D) The ER membranes were purified from middle-density fractions derived from 
ATG14 KO MEF homogenates by immunoprecipitation with FLAG-GFP-SEC61B. An 
asterisk indicates non-specific signals. The intensities of the bands in the input and IP 
fractions were measured using Image J software. The ratio of IP to input was calculated. 
 21
Each value was normalized to the ratio of IP to input of FLAG-tagged protein (co-IP 
efficiency). 
 
Figure 3. FIP200 and the ER membrane are co-purified with ATG9A-positive 
membranes from ATG3 KO MEF homogenates. 
(A-C) Purification of ATG9A-positive membranes. ATG3 KO MEFs expressing 
indicated constructs were cultured in regular DMEM and subjected to Optiprep flotation 
analysis as shown in Fig 1E. FLAG-ATG9A-enriched membranes were purified from 
the top fraction (Fraction 1) (A) and middle-density fractions (Fractions 4-7) (B, C). 
The immunoprecipitation efficiency was calculated as in Figure 2.  
(D) Summary of autophagic membrane purification. FIP200 was co-precipitated with 
the ER membranes purified from middle density fractions of ATG14 KO homogenates 
(ATG14 KO, Fr. 4-7) (Fig 2D). The FLAG-ATG9A immunoprecipitates from the 
middle-density fractions of ATG3 KO homogenates contained the ER marker SEC61B 
and GFP-ATG14 as well as small amounts of FIP200 and WIPI2, which might reflect 
the ER-isolation membrane contact (ATG3 KO, Fr. 4-7) (Fig 3B, C). FIP200 and the 
isolation membrane protein WIPI2 were co-precipitated with ATG9A-enriched 
membrane from the top fraction of ATG3 KO homogenates (ATG3 KO, Fr. 1) (Fig 3A).  
 
Figure 4. Several phospholipid biosynthetic enzymes colocalize with FIP200 in 
wortmannin-treated cells under starvation conditions. 
(A) The phospholipid synthesis pathways in mammalian cells. De novo synthesis (top) 
and remodeling (bottom) pathways are shown. Enzymes that colocalize with 
endogenous FIP200 in WT MEFs cultures in starvation medium in the presence of 200 
nM wortmannin for 1 h are shown in red, and those that do not colocalize are shown in 
blue.  
(B) WT MEFs stably expressing the indicated GFP- or FLAG-tagged enzymes were 
cultured in starvation medium in the presence or absence of 200 nM wortmannin for 1 h. 
The cells were fixed and stained with anti-FIP200 antibody. Subcellular distributions of 
the indicated enzymes and FIP200 were examined by immunofluorescence microscopy. 
The cells were classified into three categories based on the colocalization of the 
indicated enzyme and FIP200: Clear colocalization (red), partial colocalization (green), 
and no colocalization (blue). More than 30 cells were analyzed for each protein. 
 
Figure 5. FIP200 is recruited to PIS-enriched ER subdomains at the initiation 
stage of autophagy. 
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(A) WT or ATG14 KO MEFs stably expressing PIS-GFP were cultured in regular 
DMEM or starvation medium in the presence of wortmannin (WM) for 1 h.  
(B) Quantification of the number of FIP200+PIS- and FIP200+PIS+ puncta in growing 
cells and wortmannin-treated starved cells. The number of puncta was quantified from 
more than 60 randomly selected cells from three independent samples as described in 
the Methods. Data represent mean ± SEM. * P < 0.0001 vs. growing condition.  
(C) HeLa cells stably expressing PIS-GFP were cultured in starvation medium in the 
presence of wortmannin for 1 h. Cells were analyzed by immunofluorescence 
microscopy using anti-FIP200 and anti-SEC31A antibodies.  
(D) WT MEFs stably expressing PIS-GFP were cultured in starvation medium in the 
presence of wortmannin for 1 h. For mitochondrial staining, cells were treated with 50 
nM Mitotracker Red CMXRos for 15 min before fixation. Scale bars, 10 μm (A, C, and 
D).  
(E) PIS-GFP-FLAG was precipitated from the middle-density fractions of ATG14 KO 
MEF homogenates in the absence or presence of 1% Triton X-100. The resulting 
precipitates were examined by immunoblot analysis with the indicated antibodies.  
 
Figure 6. Super-resolution structured illumination microscopy of association of 
FIP200 with the PIS-enriched ER subdomains. 
(A, B) WT MEFs stably expressing PIS-GFP were cultured in starvation medium in the 
absence (A) or presence (B) of wortmannin (WM) for 1 h. The cells were fixed and 
stained with anti-FIP200 antibody.  
(C) Quantification of experiments in A and B. FIP200 puncta were classified into three 
categories: “colocalized” with PIS-GFP, “associated” with (next to) PIS-GFP, and 
“non-associated” with (away from) PIS-GFP. Experimental conditions are indicated in 
panels: starvation (St) (A) or starvation with wortmannin (St+WM) (B). More than 100 
puncta were analyzed. Scale bars, 5 μm (A, B), 0.2 μm (insets, C). 
 
Figure 7. Puncta formation of the ULK complex on PIS-positive structures in live 
cells. 
(A, B) Two representative live-cell time-lapse images of WT MEFs stably expressing 
Venus-ULK1 and SECFP-PIS. Cells were cultured in starvation medium and observed 
using a DeltaVision microscopy system. Frames were captured every 10 s. White 
arrowheads indicate colocalization of Venus-ULK1 with SECFP-PIS. Some 
Venus-ULK1 puncta were detached from SECFP-PIS puncta at last 2–3 frames before 
disappearance (indicated by yellow arrowheads) (see Movies EV1 and 2).  
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(C) Quantification of colocalization of newly formed Venus-ULK1 puncta and 
PIS-positive punctate or reticular structures. To identify newly formed ULK1 puncta, 
sequential images were subjected to single-particle tracking analysis. More than 90 
areas were analyzed.  
 
Figure 8. PI in the PIS-enriched membranes is required for isolation membrane 
formation. 
(A) PISHQ-GFP-PIPLC MEFs were pre-cultured in the absence or presence of 2 μg/ml 
doxycycline (DOX) for 4 h to induce PISHQ-GFP-PIPLC expression. The level of PI 
was measured by liquid chromatography-electrospray ionization-tandem mass 
spectrometry. Values indicate individual molecular species of PI.  
(B) Autophagic flux assay. PISHQ-GFP-PIPLC MEFs were pre-treated with DOX for 8 
h and then cultured in regular DMEM or starvation medium in the presence or absence 
of 100 nM bafilomycin A1 (BafA1) for 2 h.  
(C, D) PISHQ-GFP-PIPLC MEFs were pre-cultured in the absence or presence of DOX 
for 4 h and then cultured in starvation medium for 1 h.  
(E) Quantification of the number of WIPI2 puncta. In DOX-treated condition, the 
number of WIPI2 puncta was quantified from the cells expressing PISHQ-GFP-PIPLC. 
Data present mean ± SEM.* P < 0.0001 vs. DOX-untreated cells.  
(F) PISHQ-GFP-PIPLC MEFs stably expressing mRFP-2xFYVE were pre-treated with 
DOX for 3 h and then cultured in starvation medium with DOX for 1 h.  
(G) RFP-PIPLC MEFs were pre-cultured in the absence or presence of DOX for 24 h. 
Scale bars, 10 μm (C, D, F, and G).  
(H) Model of the initial stages of autophagosome formation. The ULK complex 
translocates to the PIS-enriched ER subdomains and induces recruitment of downstream 
factors such as ATG14. At least a part of ATG9A is incorporated into the isolation 
membrane. The PIS-enriched ER membrane supplies PI (and/or PI3P) to ATG9A 
vesicles or isolation membrane precursors, leading to isolation membrane formation.  
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Expanded View Figure Legends 
 
Figure EV1. FIP200 is recruited to membrane structures independently of the 
other ULK complex components and ATG9A. 
(A) WT MEFs stably expressing FLAG-ATG9A were cultured in starvation medium for 
2 h and subjected to Optiprep membrane flotation analysis as in Fig 1A. Asterisk 
indicates the fractions of floated Atg proteins.  
(B) Validation of ATG KO cell lines. WT and various ATG KO MEFs were analyzed 
by immunoblotting using the indicated antibodies. 
(C-F) FIP200 KO (C), ULK1/2 DKO (D), ATG13 KO (E), and ATG101 KO MEFs (F) 
were cultured in regular DMEM and subjected to Optiprep membrane flotation analysis. 
Asterisks indicate the flotation of FIP200 into middle-density fractions.  
(G) The indicated ATG KO MEFs were cultured in starvation medium for 1 h and 
analyzed by immunofluorescence microscopy using anti-FIP200 antibody.  
(H) WT MEFs stably expressing GFP-ATG9A were cultured in starvation medium in 
the presence or absence of 200 nM wortmannin for 1 h. Cells were fixed and analyzed 
by immunofluorescence microscopy using anti-FIP200 and WIPI2 antibodies. Scale 
bars, 10 μm (G, H).  
 
Figure EV2. Separation of autophagy-related membranes in ATG9A KO and 
ATG14 KO cells. 
(A-C) The indicated MEF cells were cultured in regular DMEM and subjected to 
Optiprep floatation analysis as shown in Fig 1E. Asterisks indicate the flotation of 
FIP200 into middle-density fractions (B, C). 
 
Figure EV3. The effect of starvation on PIS-GFP expression. 
WT MEFs stably expressing PIS-GFP were cultured in growing or starvation conditions 
in the presence of the indicated inhibitor for 4 h. Then, 200 nM wortmannin (WM), 100 
nM bafilomycin A1 (BafA1), 10 μM MG132, and 5 μg/ml brefeldin A (BFA) were used. 
Note that p62 but not PIS-GFP was degraded in an autophagy dependent manner under 
starvation conditions.  
 
Figure EV4. No colocalization of PIS puncta with ERGIC53 in 
wortmannin-treated cells under starvation conditions. 
WT MEFs stably expressing PIS-GFP were cultured in starvation medium in the 
presence of 200 nM wortmannin for 1 h. Cells were analyzed by immunofluorescence 
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microscopy using anti-ERGIC53 antibody. Scale bar, 10 μm. 
 
Figure EV5. Lipid analysis of recombinant PIPLC-treated cell homogenates and 
PISHQ-PIPLC-expressing cells. 
(A) WT MEF homogenates were treated with 6.25 μg/ml recombinant PIPLC (rPIPLC) 
for 30 min at 37°C. Phospholipids were extracted by the methanol method and 
subjected to LC-ESI-MS/MS analysis. The MS spectra of the indicated phospholipids 
are shown.  
(B) PISHQ-GFP-PIPLC MEFs were pre-cultured in the absence or presence of 2 μg/ml 
doxycycline (DOX) for 4 h to induce PISHQ-GFP-PIPLC expression. Phospholipids 
were extracted and analyzed as in (A). The prefix “e” indicates a chain with an ether 
linkage. Note that CDP-DAG were increased as a compensatory reaction. 
PI, phosphatidylinositol; PC, phosphatidylcholine; SM, sphingomyelin; PE, 
phosphatidylethanolamine; PS, phosphatidylserine; 
PA, phosphatidic acid; CDP-DAG, cytidine diphosphate-diacylglycerol. 
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